Epitope analysis of insulin autoantibodies using recombinant Fab

C J Padoa, N J Crowther, J W Thomas, T R Hall, L M Bekris, Carina Törn, Mona Landin-Olsson, E Ortqvist, J P Palmer, Åke Lernmark, C S Hampe

Research output: Contribution to journalArticlepeer-review

13 Citations (SciVal)


Autoantibodies to insulin are often the first autoantibodies detected in young children with type 1 diabetes and can be present before the onset of clinical diabetes. These autoantibodies and their epitopes are, however, not well characterized. We explored the use of monoclonal antibodies and their recombinant Fab as reagents for epitope analysis. In this study we cloned and characterized the recombinant Fab of the insulin-specific monoclonal antibody CG7C7. We found the epitope of this antibody to be located predominantly at the A-chain loop of the insulin molecule. The recombinant Fab was then used to compete for insulin binding against insulin autoantibodies present in sera from patients with type 1 or type 1.5 diabetes. In competition experiments with sera positive for autoantibodies to insulin the recombinant Fab significantly reduced the binding to [I-125]-insulin by sera of type 1 (n = 35) and type 1.5 diabetes [latent autoimmune diabetes in adults (LADA)] (n = 14) patients (P < 0.0001). We conclude that competition between insulin-specific monoclonal antibodies or their recombinant Fab and insulin autoantibodies should prove useful in the epitope analysis of autoantibodies to insulin.
Original languageEnglish
Pages (from-to)564-571
JournalClinical and Experimental Immunology
Issue number3
Publication statusPublished - 2005

Subject classification (UKÄ)

  • Immunology in the medical area


  • type 1 diabetes
  • epitopes
  • insulin autoantibody
  • radioligand binding
  • assay
  • recombinant Fab


Dive into the research topics of 'Epitope analysis of insulin autoantibodies using recombinant Fab'. Together they form a unique fingerprint.

Cite this